COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK
29.96
22-November-24 15:44:58
15 minutes delayed
Stocks
-0.45
-1.48%
Today's range
29.80 - 30.76
ISIN
N/A
Source
NASDAQ
-
Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
28 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe
06 Dec 2021 08:29:37 By Nasdaq GlobeNewswire
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
15 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
-
UPDATE: Collegium to Participate in Upcoming Conferences
11 Nov 2021 15:54:42 By Nasdaq GlobeNewswire
-
Collegium Participate in Upcoming Conferences
11 Nov 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Reports Third Quarter Fiscal 2021 Results
04 Nov 2021 15:01:10 By Nasdaq GlobeNewswire
-
21 Oct 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference
13 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
Collegium to Participate in Upcoming Investor Conferences
01 Sep 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Announces $100 Million Share Repurchase Program
16 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
05 Aug 2021 15:01:02 By Nasdaq GlobeNewswire
-
21 Jul 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Announces Publication of Real-World Data in Journal of Pain Research
16 Jun 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium to Participate in Upcoming Investor Conference
20 May 2021 15:05:00 By Nasdaq GlobeNewswire
-
Collegium Reports Record Quarterly Revenue of $87.7 Million
06 May 2021 15:01:02 By Nasdaq GlobeNewswire
-
15 Apr 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million
25 Feb 2021 15:01:01 By Nasdaq GlobeNewswire
-
11 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
Collegium Provides 2021 Financial Guidance
06 Jan 2021 15:01:00 By Nasdaq GlobeNewswire